GLP-1s and the Thin Ideal

# GLP-1s and the Thin Ideal **Key Points:** - GLP-1 access carries psychological impact in a culture that equates thinness with worth. - Using GLP-1s to pursue thinness can reinforce body surveillance and shame. - Appetite suppression may mask or reactivate eating disorders. - Weight regain after stopping GLP-1s can intensify body dissatisfaction. GLP-1 medications are being discussed everywhere right now: in medical offices, on social media, and in celebrity interviews. However, it's important to consider the implications of making a powerful appetite drug widely accessible in a culture that equates thinness with worth. ### When a Prescription Starts to Look Like a Diet GLP-1 medications were initially developed for specific medical indications, but as access expands, many people seek them out primarily for weight loss—not to treat a diagnosed condition but to align with societal standards of beauty. The concept of “microdosing,” where individuals take smaller amounts of the drug to blunt appetite, is becoming common. This approach often resembles dieting, which carries inherent risks. Dieting can lead to cyclic behaviors: when the body faces deprivation, it naturally increases hunger and slows metabolism. What is often labeled as “failure” is simply biological response. ### The Cycle Beneath the Promise GLP-1 use can result in the loss of lean muscle mass along with fat. After discontinuation of the medication, weight regain typically occurs, favoring fat over muscle. This pattern creates a destabilizing cycle: lose weight, regain it, feel shame, and try again. Using a medication without a clear medical indication means not only dealing with its side effects but also facing the likelihood of rebound weight gain, which can intensify feelings of shame, especially for those whose self-worth is tied to body size. ### What This Means for Eating Disorder Recovery A significant concern arises regarding individuals with active or past eating disorders. Patients are not routinely screened for eating disorders before being prescribed GLP-1 medications, creating a critical gap. Appetite suppression can obscure the recognition of an eating disorder, masking restrictive symptoms. Individuals may appear to be “successful” while their underlying condition worsens. For those in recovery, a medication that reduces hunger cues can hinder trust rebuilding in their bodies and obstruct consistent nourishment. Clients have been observed to revert to rigid, weight-focused thinking upon introducing medication, with others experiencing relapse after weight regain. ### The Cultural Layer We Cannot Ignore GLP-1 medications are entering a multibillion-dollar weight-loss industry, long profiting from body dissatisfaction. Direct-to-consumer marketing amplifies the urgency, while social media reinforces comparison. The prevalent message is not “this is for specific medical conditions” but instead “this is how you finally fix your body.” While GLP-1 medications may have valid medical uses, framing thinness as the goal rather than targeting specific conditions reinforces body surveillance, control, and shame, affecting how people relate to their hunger, their bodies, and their self-worth. ---